What is AptarGroup's pharma — other segment items:?

AptarGroup (ATR) reported pharma — other segment items: of -$4.32M in Q1 2026.

How has AptarGroup's pharma — other segment items: changed year-over-year?

AptarGroup's pharma — other segment items: decreased by 615.6% year-over-year, from -$603K to -$4.32M.

What does pharma — other segment items: mean?

Captures miscellaneous income or expenses specific to the pharma segment that do not fall into standard operating categories. This may include restructuring charges, legal settlements, or non-recurring gains/losses.

AptarGroup (ATR) Pharma — Other Segment Items:

Screener

Other segment segments

Beauty

-$965K—

Closures

$188K—

Similar metrics at other companies

CDNSReportable Segment — Other segments items

-$58.09M-246%

IRONOther Segment Items — Segment Reporting Other Item Amount

$6.02M+2.7%

FPHTotal Operating Segments — Other segment items

-$1.17M-589%

BRTotal Reportable Segments — Other segment items

$121.4M+7.5%

IRMTOTAL REPORTABLE SEGMENTS — Other segment items

$938.34M+13.0%

CNN

CNNETotal Reportable Segments — Other segment items

$17.4M+89.1%

Other financials

Income statement

See full

Revenue$982.9M+10.8%

Gross profit$351.9M+4.6%

Operating income$107.5M-5.2%

Net income$72.7M-7.8%

EPS (diluted)$1.12-4.3%

Balance sheet

See full

Cash & equivalents$225.0M+78.8%

Total debt$1.4B+32.7%

Total equity$2.6B+3.6%

Total assets$5.1B+12.6%

Cash flow

See full

Operating cash flow$118.7M+43.5%

CapEx$65.4M+15.0%

Free cash flow$53.3M+106%

Valuation

See full

Market cap$8.69B-4.7%

Enterprise value$9.9B-2.2%

P/E22.5×-0.8×

P/S2.3×-0.3×

Profitability

See full

Gross margin36.7%-1.6pp

Operating margin12.8%-1.2pp

Net margin10%-0.4pp

FCF margin8.4%-2.1pp

Returns & leverage

See full

Return on equity15%-0.2pp

Debt / equity0.5×+0.1×

Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.

The source filing: AptarGroup’s 10-Q, filed May 1, 2026.

Filed: May 1, 2026, 11:22 AM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0000896622-26-000092

Three Months Ended March 31,	2026	2025
Beauty	52,630	46,412
Closures	24,945	23,012
Other Segment Items:
Pharma	(4,315)	(603)
Beauty	(965)	(1,891)
Closures	188	(532)
Adjusted EBITDA (1):
Pharma	$146,223	$142,450

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is AptarGroup's pharma — other segment items:?: AptarGroup (ATR) reported pharma — other segment items: of -$4.32M in Q1 2026.
How has AptarGroup's pharma — other segment items: changed year-over-year?: AptarGroup's pharma — other segment items: decreased by 615.6% year-over-year, from -$603K to -$4.32M.
What does pharma — other segment items: mean?: Captures miscellaneous income or expenses specific to the pharma segment that do not fall into standard operating categories. This may include restructuring charges, legal settlements, or non-recurring gains/losses.